Építés alatt – nem éles oldal
Belépés

Szarkóma trials, also abroad

635 open Szarkóma trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.

OrszágOpen trials
Egyesült Államok301
Kína106
Franciaország71
Olaszország52
Spanyolország39
All other countries

The same trial often runs in several countries

A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC) has 2 sites in Hongkong and runs in 21 countries. If a site near you is full, another one may still take people.

See A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC) in all 21 countries